Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.55 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.37 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.37 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677749 | 0.83 | GABRA1 (0.56) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL17748247 | 0.81 | GABRA1 (0.42) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL16241052 | 0.81 | GABRA1 (0.55) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL17749073 | 0.81 | SRC (0.45) | GABRA1GABRB2LMNACYP2C9ALB | |
| SCHEMBL28986692 | 0.80 | TYR (0.56) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL17160035 | 0.80 | GABRA1 (0.53) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL17761413 | 0.80 | GABRA1 (0.41) | GABRA1GABRB2PTGS1PTGS2LMNA | |
| SCHEMBL3024106 | 0.80 | GABRA1 (0.34) | GABRA1GABRB2TYR | |
| SCHEMBL454314 | 0.77 | ALDH1A1 (0.54) | LMNATSHRPOLBMAPTALDH1A1 | |
| SCHEMBL10839254 | 0.77 | GABRA1 (0.39) | GABRA1GABRB2PTGS1PTGS2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1524256-B1 | Production method of alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL CO (JP) | 2008-12-17 | — | — | EP | disclosed |
| CN-100366600-C | Method for producing alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL CO (JP) | 2008-02-06 | — | — | CN | disclosed |
| US-7154008-B2 | Production method of alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-12-26 | — | — | US | disclosed |
| CN-1660747-A | Method for producing alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL CO (JP) | 2005-08-31 | — | — | CN | disclosed |
| US-20050085670-A1 | Production method of alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-04-21 | — | — | US | disclosed |
| EP-1524256-A1 | Production method of alkylbenzaldehydes | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085670-A1 | Production method of alkylbenzaldehydes | AFF2, TBCB, FGB | GABRA1 855/4885GABRB2 458/4885PTGS1 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.